Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
25.00
+0.91 (3.78%)
At close: Jul 2, 2026, 4:00 PM EDT
24.87
-0.13 (-0.52%)
After-hours: Jul 2, 2026, 7:40 PM EDT
Elanco Animal Health Stock Forecast
Stock Price Forecast
According to 17 analysts polled by S&P Global, Elanco Animal Health stock has a consensus rating of "Strong Buy" and an average price target of $29.86. The average 1-year stock price forecast is 19.44% higher than the current stock price, while the lowest is $23 (-8.00%) and the highest is $32 (+28.00%).
Price Target: $29.86 (+19.44%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Elanco Animal Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 10 | 10 | 11 | 11 | 11 |
| Buy | 4 | 4 | 4 | 4 | 5 | 5 |
| Hold | 3 | 2 | 2 | 2 | 1 | 1 |
| Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 17 | 17 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Reiterates $30 | Buy | Reiterates | $30 | +20.00% | Jun 29, 2026 |
| Argus Research | Argus Research | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 24, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $31 → $32 | Buy | Reiterates | $31 → $32 | +28.00% | Jun 18, 2026 |
| Barclays | Barclays | Buy Maintains $30 | Buy | Maintains | $30 | +20.00% | Jun 11, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $32 | Buy | Maintains | $32 | +28.00% | Jun 5, 2026 |
Financial Forecast
Revenue This Year
5.06B
from 4.72B
Increased by 7.25%
Revenue Next Year
5.33B
from 5.06B
Increased by 5.32%
EPS This Year
1.07
from 0.94
Increased by 13.37%
EPS Next Year
1.19
from 1.07
Increased by 11.55%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.1B | ||
| Avg | 5.1B | ||
| Low | 5.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 8.4% | ||
| Avg | 7.2% | ||
| Low | 5.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.10 | ||
| Avg | 1.07 | ||
| Low | 1.02 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 17.0% | ||
| Avg | 13.4% | ||
| Low | 8.8% |